Home/Filings/4/0000905148-24-000112
4//SEC Filing

Hyllengren Eric J 4

Accession 0000905148-24-000112

CIK 0001604464other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:40 PM ET

Size

5.1 KB

Accession

0000905148-24-000112

Insider Transaction Report

Form 4
Period: 2024-01-08
Hyllengren Eric J
EVP, CFO and COO
Transactions
  • Award

    Common Stock

    2024-01-08+475,000680,998 total
Footnotes (1)
  • [F1]These restricted stock units vest as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the second Quarterly Vesting Date (as defined below) following January 8, 2024, and as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the next seven Quarterly Vesting Dates, such that all of the shares shall be vested on the last Quarterly Vesting Date, subject to the reporting person's continuous service. "Quarterly Vesting Date" means March 1, May 15, August 15, and November 15 of each year, provided that if such date falls on a weekend or holiday, the Quarterly Vesting Date shall be the first business day after such date.

Documents

1 file

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1
  • filerCIK 0001966926

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:40 PM ET
Size
5.1 KB